Common-Size Income Statement
Quarterly Data
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
The common-size income statement reveals several noteworthy trends in the company’s financial performance between March 2021 and December 2025. Net revenues are consistently represented as 100% by definition, allowing for a clear view of the proportional changes in other income statement items. Cost of sales as a percentage of net revenues generally increased over the period, with a significant rise observed between 2021 and 2022, before stabilizing and decreasing slightly in later periods. This impacts gross profit, which correspondingly decreased initially before showing some recovery.
- Gross Profit Margin
- Gross profit margin, initially at 70.02% in March 2021, experienced a decline to 60.61% by December 2022. It then showed some improvement, reaching 65.64% in December 2025. This suggests potential pressures on pricing or increases in production costs during the 2021-2022 timeframe, followed by some mitigation efforts.
Marketing, administration, and research costs represent a substantial portion of net revenues, fluctuating between approximately 23% and 33% throughout the analyzed period. A notable increase is observed in December 2024, reaching 33.09%, and again in December 2025, reaching 33.09%. This suggests increased investment in these areas towards the end of the period.
- Operating Income Margin
- Operating income margin mirrored the trends in gross profit, declining from 45.41% in March 2021 to 33.58% in December 2024, before a partial recovery to 32.55% in December 2025. This indicates that changes in both cost of sales and operating expenses significantly impacted profitability.
Interest expense remained relatively stable as a percentage of net revenues for most of the period, generally between 1.6% and 3.3%. However, a significant spike occurred in December 2024, reaching 3.36%. Pension and other employee benefit costs remained consistently low, generally below 1%, with a slight increase towards the end of the period. A significant, but isolated, impact from impairment related to the RBH equity investment was observed in December 2024, reducing net earnings by 23.86% of net revenues.
- Net Earnings Margin
- Net earnings margin experienced a substantial decline from 34.21% in March 2021 to 18.76% in June 2023, largely influenced by the factors affecting gross profit and operating income, as well as the impairment charge in December 2024. While there was some recovery in subsequent periods, reaching 21.71% in December 2025, it remained below the initial levels. The impact of noncontrolling interests is consistently around 2% of net revenues.
Equity investments and securities income (loss), net, fluctuated considerably, ranging from a loss of 2.22% in December 2024 to a gain of 5.04% in September 2024. This volatility suggests the impact of market conditions or specific investment decisions on the company’s bottom line. Provision for income taxes as a percentage of net revenues also varied, with a notable increase in September 2023, reaching 11.28%.